Detalles de la búsqueda
1.
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: Results of the multicenter KMMWP2201 study.
Haematologica
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841794
2.
Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.
Ann Hematol
; 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267559
3.
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
Ann Hematol
; 102(8): 2233-2240, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392367
4.
Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
Cytokine
; 129: 155048, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135464
5.
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
Ann Hematol
; 99(2): 255-264, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31897676
6.
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Ann Hematol
; 99(2): 309-319, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872360
7.
Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma.
Cytokine
; 113: 371-379, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30327172
8.
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
BMC Cancer
; 19(1): 1080, 2019 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707975
9.
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.
Ann Hematol
; 98(11): 2541-2550, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31493002
10.
Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
Invest New Drugs
; 34(1): 1-14, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581399
11.
Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study.
Clin Lymphoma Myeloma Leuk
; 24(2): e50-e57.e2, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37973459
12.
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea.
Cancer Res Treat
; 56(2): 681-687, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946408
13.
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.
Nat Commun
; 15(1): 2776, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555311
14.
Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
Oncology
; 85(5): 283-9, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24217184
15.
Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.
Ann Hematol
; 92(4): 459-69, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23262795
16.
The primary extra-gastrointestinal stromal tumor of pleura: a case report and a literature review.
Jpn J Clin Oncol
; 43(12): 1269-72, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24168806
17.
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study.
Blood Res
; 58(4): 194-200, 2023 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031473
18.
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.
Expert Opin Biol Ther
; 23(8): 737-747, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36757373
19.
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts.
Cancer Res Treat
; 55(1): 325-333, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468269
20.
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).
Cancer Res Treat
; 55(2): 684-692, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596727